Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1.
Published June 20, 2012 · Recall initiated: May 1, 2012
Summary
FDA records drug Class II recall D-1377-2012, published June 20, 2012 and initiated May 1, 2012. Recalling firm: Ben Venue Laboratories Inc; Status: Terminated; Reported quantity: 6,515 packs; Lot: Lot # 2006500, Exp 08/31/12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ben Venue Laboratories Inc
- Distributor
- Nationwide and Puerto Rico.
- Lot
- Lot # 2006500, Exp 08/31/12
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACYTARAbine for Injection USP, lyophiled in glass vials, 1 gram per vial, Rx only, Distributed by BedfordAugust 27, 2014
- FDAAcetylcysteine Solution, USP, 10%, 30 mL vial, Rx only, Ben Venue Laboratories, Inc., Bedford, OH, NDCMay 28, 2014
- FDALeucovorin Calcium Injection USP, single use vials, 10mg/mL; 50mL, Rx only, Manufactured by: Ben Venue Labs,November 7, 2012
- FDAVecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized powder perOctober 3, 2012
- FDAMidazolam HCl Injection, 5 mg/mL, 1 mL single use vials, packaged in 10 x 1 mL single use vials per pack, RxJune 20, 2012
- FDACONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4% a) 30 mL SINGLE DOSE VIAL, (NDC 0517-2930-25), b) 100 mLJune 20, 2012
Questions about this recall
Was Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1. recalled?
Yes. FDA published recall D-1377-2012 on June 20, 2012. Reported hazard: Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter